Last News

Besides following our news, follow us on socials networks :

Champions Oncology, Inc. (NASDAQ: CSBR) signs a strategic partnership with TransCure bioServices SAS 31 May 2019

Strategic partnership with Champions Oncology, Inc

Read more
TransCure’s proposal for Horizon 2020 has been selected by the European Research & Innovation funding program 22 May 2019

TransCure bioServices SAS was selected for the SME instruments call-to-offer Phase 1 with 273 companies out of 2’822 applicants.

Read more
Adrien MOSSU, new Deputy Project Officer, has been hired by TransCure bioServices 23 April 2019

TransCure bioServices hires Adrien MOSSU – New Deputy Project Officer

Read more
TransCure bioServices involved in INSERM results 11 April 2019

INSERM publishes first in vivo proof of concept of an engineered Chimeric Antigen Receptor T cell directed against IL-1RAP expressed by leukemia stem cells using TransCure’s full human immune system hu-mouse models.

Read more
They talk about us in Labiotech – Inflammatory Bowel Diseases 9 April 2019

Find more about how TransCure improves Inflammatory Bowel Diseases research with its humanized mouse model.

Read more
Benjamin TSCHUMI, new Deputy Project Officer, has been hired by TransCure bioServices 4 April 2019

TransCure bioServices hires Benjamin TSCHUMI – New Deputy Project Officer

Read more